Data search
Results for MligTC455_21178
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_21178 | 29 | 0.59 | Mlig455_001203, Mlig455_066754, Mlig455_069710 | Neo: - Age: Down-Up-Down |
CCKAR, NPFFR1 | Mlig455_001203 {REF} {Length: 4789} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=109.9]} {Human: ENSG00000163394, CCKAR, cholecystokinin A receptor, [Score=60.5, Expect=3e-09]; ENSG00000148734, NPFFR1, neuropeptide FF receptor 1, [Score=58.5, Expect=9e-09]} {Mouse: ENSMUSG00000020090, Npffr1, neuropeptide FF receptor 1, [Score=59.3, Expect=3e-09]; ENSMUSG00000019865, Nmbr, neuromedin B receptor, [Score=58.2, Expect=4e-09]; ENSMUSG00000029193, Cckar, cholecystokinin A receptor, [Score=56.6, Expect=3e-08]; ENSMUSG00000035528, Npffr2, neuropeptide FF receptor 2, [Score=56.6, Expect=2e-08]} {Dmel: FBgn0038542, TyrR, Tyramine receptor, [Score=65.5, Expect=4e-11]} {Celegans: WBGene00004778, ser-3, SERotonin/octopamine receptor family, [Score=58.5, Expect=5e-09]} {Smed: dd_Smed_v6_43180_0_1, dd_Smed_v6_43180_0_1, [Score=72.4, Expect=4e-14]} {RNA1310_113134} Mlig455_066754 {REF} {Length: 3197} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=84.3]} {Human: ENSG00000148734, NPFFR1, neuropeptide FF receptor 1, [Score=52.8, Expect=6e-07]} {Mouse: ENSMUSG00000020090, Npffr1, neuropeptide FF receptor 1, [Score=54.7, Expect=1e-07]} {Dmel: FBgn0038542, TyrR, Tyramine receptor, [Score=53.5, Expect=2e-07]} {Celegans: WBGene00006428, tkr-3, TachyKinin Receptor family, [Score=50.1, Expect=1e-06]} {Smed: dd_Smed_v6_16725_0_1, dd_Smed_v6_16725_0_1, [Score=52.8, Expect=2e-07]} {RNA1310_131269} Mlig455_069710 {REF} {Length: 1208} {NoTransDecoderORF} {RNA1310_131269} |
Cumulative graph for MligTC455_21178
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | 0.721 | 1.181 | 0.99966 | 1.00000 | |
| RegionR2 | 4.069 | 1.181 | 0.12977 | 0.44704 | |
| RegionR3 | 0.24 | 1.181 | 0.61874 | 1.00000 | |
| RegionR4 | 2.384 | 1.181 | 0.17190 | 0.43639 | |
| RegionR5 | 0.406 | 1.181 | 0.51532 | 0.87817 | |
| RegionR6 | -3.347 | 1.181 | 0.99961 | 1.00000 | |
| RegionR7 | -2.192 | 1.181 | 0.99969 | 1.00000 | |
| RegionR8 | -2.282 | 1.181 | 0.99969 | 1.00000 |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | -1.351 | 1.181 | 0.99993 | 1.00000 | |
| RegenerationR2 | -2.446 | 1.181 | 0.05550 | 0.38794 | |
| RegenerationR3 | 0.075 | 1.181 | 0.86362 | 1.00000 | |
| RegenerationR4 | -3.797 | 1.181 | 0.01978 | 0.22111 | |
| RegenerationR5 | 0.93 | 1.181 | 0.66922 | 0.94043 | |
| RegenerationR6 | 3.756 | 1.181 | 0.09749 | 0.38846 | |
| RegenerationBL | 0.353 | 1.181 | 0.99999 | 1.00000 | |
| RegenerationTP | -0.601 | 1.181 | 0.99993 | 1.00000 |
Genes with expression patterns similar to MligTC455_21178
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_21178 | 29 | 0.59 | Mlig455_001203, Mlig455_066754, Mlig455_069710 | Neo: - Age: Down-Up-Down |
CCKAR, NPFFR1 | 6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_001203 {REF} {Length: 4789} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=109.9]} {Human: ENSG00000163394, CCKAR, cholecystokinin A receptor, [Score=60.5, Expect=3e-09]; ENSG00000148734, NPFFR1, neuropeptide FF receptor 1, [Score=58.5, Expect=9e-09]} {Mouse: ENSMUSG00000020090, Npffr1, neuropeptide FF receptor 1, [Score=59.3, Expect=3e-09]; ENSMUSG00000019865, Nmbr, neuromedin B receptor, [Score=58.2, Expect=4e-09]; ENSMUSG00000029193, Cckar, cholecystokinin A receptor, [Score=56.6, Expect=3e-08]; ENSMUSG00000035528, Npffr2, neuropeptide FF receptor 2, [Score=56.6, Expect=2e-08]} {Dmel: FBgn0038542, TyrR, Tyramine receptor, [Score=65.5, Expect=4e-11]} {Celegans: WBGene00004778, ser-3, SERotonin/octopamine receptor family, [Score=58.5, Expect=5e-09]} {Smed: dd_Smed_v6_43180_0_1, dd_Smed_v6_43180_0_1, [Score=72.4, Expect=4e-14]} {RNA1310_113134} Mlig455_066754 {REF} {Length: 3197} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=84.3]} {Human: ENSG00000148734, NPFFR1, neuropeptide FF receptor 1, [Score=52.8, Expect=6e-07]} {Mouse: ENSMUSG00000020090, Npffr1, neuropeptide FF receptor 1, [Score=54.7, Expect=1e-07]} {Dmel: FBgn0038542, TyrR, Tyramine receptor, [Score=53.5, Expect=2e-07]} {Celegans: WBGene00006428, tkr-3, TachyKinin Receptor family, [Score=50.1, Expect=1e-06]} {Smed: dd_Smed_v6_16725_0_1, dd_Smed_v6_16725_0_1, [Score=52.8, Expect=2e-07]} {RNA1310_131269} Mlig455_069710 {REF} {Length: 1208} {NoTransDecoderORF} {RNA1310_131269} |
| 2. | MligTC455_20957 | 40 | 0.84 | Mlig455_009152 | Neo: - Age: - |
2.671 | 0.788 | - | 0.999 | - | - | 0.884 | Mlig455_009152 {REF} {Length: 1951} {RNA1310_39190} {RNA815_29274} | |
| 3. | MligTC455_12102 | 59 | 1.23 | Mlig455_041538, Mlig455_053099 | Neo: - Age: - Region-enriched R2: 6.626/0.00371 |
DEGS2 | 2.601 | 0.718 | 0.906 | 0.977 | - | - | - | Mlig455_041538 {REF} {Length: 1966} {Pfam: Fatty acid desaturase [PF00487.26, score=87.9]; Sphingolipid Delta4-desaturase (DES) [PF08557.12, score=57.6]} {Human: ENSG00000168350, DEGS2, delta 4-desaturase, sphingolipid 2, [Score=319, Expect=2e-107]; ENSG00000143753, DEGS1, delta 4-desaturase, sphingolipid 1, [Score=315, Expect=5e-106]} {Mouse: ENSMUSG00000038633, Degs1, delta(4)-desaturase, sphingolipid 1, [Score=308, Expect=2e-103]; ENSMUSG00000021263, Degs2, delta(4)-desaturase, sphingolipid 2, [Score=307, Expect=6e-103]} {Dmel: FBgn0001941, ifc, infertile crescent, [Score=345, Expect=5e-118]} {Celegans: WBGene00017996, F33D4.4, Putative sphingolipid delta(4)-desaturase, [Score=318, Expect=4e-107]} {Smed: dd_Smed_v6_7414_0_1, dd_Smed_v6_7414_0_1, [RH, Score=409, Expect=7e-143]} {RNA1310_20672.2} {RNA815_19986} Mlig455_053099 {REF} {Length: 2009} {Pfam: Fatty acid desaturase [PF00487.26, score=87.9]; Sphingolipid Delta4-desaturase (DES) [PF08557.12, score=57.5]} {Human: ENSG00000168350, DEGS2, delta 4-desaturase, sphingolipid 2, [Score=319, Expect=2e-107]; ENSG00000143753, DEGS1, delta 4-desaturase, sphingolipid 1, [Score=315, Expect=4e-106]} {Mouse: ENSMUSG00000038633, Degs1, delta(4)-desaturase, sphingolipid 1, [Score=309, Expect=7e-104]; ENSMUSG00000021263, Degs2, delta(4)-desaturase, sphingolipid 2, [Score=307, Expect=5e-103]} {Dmel: FBgn0001941, ifc, infertile crescent, [Score=345, Expect=4e-118]} {Celegans: WBGene00017996, F33D4.4, Putative sphingolipid delta(4)-desaturase, [Score=318, Expect=3e-107]} {Smed: dd_Smed_v6_7414_0_1, dd_Smed_v6_7414_0_1, [RH, Score=409, Expect=4e-143]} {RNA1310_20672.1} {RNA815_19986} |
| 4. | MligTC455_29238 | 48 | 1.01 | Mlig455_063305 | Neo: - Age: - |
2.576 | 0.760 | 0.828 | - | 0.988 | - | - | Mlig455_063305 {REF} {Length: 892} {TRANSSPLICED} {RNA1310_67367} {RNA815_37220} | |
| 5. | MligTC455_41011 | 90 | 1.87 | Mlig455_014030, Mlig455_014036 | Neo: - Age: Down-Up-Down |
2.561 | - | - | 0.736 | 0.989 | - | 0.836 | Mlig455_014030 {REF} {Length: 1659} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=41.2]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=36.2]} {Smed: dd_Smed_v6_19397_0_1, dd_Smed_v6_19397_0_1, [Score=95.1, Expect=2e-21]} {RNA1310_70554} {RNA815_47734} Mlig455_014036 {REF} {Length: 1980} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=51.3]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=47.7]} {Smed: dd_Smed_v6_19397_0_1, dd_Smed_v6_19397_0_1, [Score=104, Expect=3e-24]} {RNA1310_70554} {RNA815_47734} |
|
| 6. | MligTC455_18139 | 70 | 1.45 | Mlig455_010809 | Neo: - Age: logFC(26M/2M)=-0.809 Region-enriched R2: 6.868/0.00081 |
TRPC5 | 2.545 | 0.745 | 0.970 | 0.830 | - | - | - | Mlig455_010809 {REF} {Length: 4442} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.1]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.4]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=740, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=744, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=740, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=694, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1017, Expect=0.0]} {RNA1509_34138} {RNA1310_12839, RNA1509_34138} {RNA1509_34138, RNA815_17637} |
| 7. | MligTC455_18171 | 108 | 2.25 | Mlig455_034306, Mlig455_067304, Mlig455_067320 | Neo: - Age: Down-Up-Down Region-enriched R2: 4.816/0.02161 Regeneration-upregulated BL: 6.953 Regeneration-enriched BL: 6.953 |
2.522 | 0.779 | 0.748 | 0.995 | - | - | - | Mlig455_034306 {REF} {Length: 840} {TRANSSPLICED} {RNA1310_58083} {RNA815_58789} Mlig455_067304 {REF} {Length: 733} {TRANSSPLICED} {RNA1310_58083} {RNA815_58789} Mlig455_067320 {REF} {Length: 454} {RNA1310_58083} {RNA815_58789} |
|
| 8. | MligTC455_19249 | 90 | 1.86 | Mlig455_054092 | Neo: - Age: Down-Up-Up Region-enriched R2: 7.298/0.00139 |
2.44 | 0.746 | 0.727 | 0.967 | - | - | - | Mlig455_054092 {REF} {Length: 667} {TRANSSPLICED} {RNA1509_57448} {RNA1310_51394, RNA1509_57448} {RNA1509_57448, RNA815_26076} | |
| 9. | MligTC455_04142 | 25 | 0.52 | Mlig455_035034, Mlig455_035041, Mlig455_053432 | Neo: - Age: - |
ANKRD28 | 2.412 | - | - | - | 1.000 | 0.710 | 0.702 | Mlig455_035034 {REF} {Length: 3334} {TRANSSPLICED} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=445.0]; Ankyrin repeats (many copies) [PF13637.8, score=368.8]; Ankyrin repeat [PF00023.32, score=323.3]; Ankyrin repeats (many copies) [PF13857.8, score=314.5]; Ankyrin repeat [PF13606.8, score=297.5]} {Human: ENSG00000206560, ANKRD28, ankyrin repeat domain 28, [RH, Score=769, Expect=0.0]; ENSG00000065413, ANKRD44, ankyrin repeat domain 44, [RH, Score=741, Expect=0.0]} {Mouse: ENSMUSG00000014496, Ankrd28, ankyrin repeat domain 28, [RH, Score=767, Expect=0.0]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=252, Expect=4e-68]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=236, Expect=3e-64]} {Smed: dd_Smed_v6_7952_0_1, dd_Smed_v6_7952_0_1, [RH, Score=520, Expect=9e-167]} {RNA1509_4645} {RNA1310_3798.1, RNA1509_4645} {RNA1509_4645, RNA815_1702} Mlig455_035041 {REF} {Length: 3306} {TRANSSPLICED} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=444.6]; Ankyrin repeats (many copies) [PF13637.8, score=368.8]; Ankyrin repeat [PF00023.32, score=322.9]; Ankyrin repeats (many copies) [PF13857.8, score=314.4]; Ankyrin repeat [PF13606.8, score=296.8]} {Human: ENSG00000206560, ANKRD28, ankyrin repeat domain 28, [RH, Score=769, Expect=0.0]; ENSG00000065413, ANKRD44, ankyrin repeat domain 44, [RH, Score=742, Expect=0.0]} {Mouse: ENSMUSG00000014496, Ankrd28, ankyrin repeat domain 28, [RH, Score=767, Expect=0.0]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=254, Expect=1e-68]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=238, Expect=6e-65]} {Smed: dd_Smed_v6_7952_0_1, dd_Smed_v6_7952_0_1, [RH, Score=521, Expect=5e-167]} {RNA1509_4645} {RNA1310_3798.1} {RNA815_1702} Mlig455_053432 {REF} {Length: 3333} {TRANSSPLICED} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=445.0]; Ankyrin repeats (many copies) [PF13637.8, score=368.8]; Ankyrin repeat [PF00023.32, score=323.3]; Ankyrin repeats (many copies) [PF13857.8, score=314.5]; Ankyrin repeat [PF13606.8, score=297.5]} {Human: ENSG00000206560, ANKRD28, ankyrin repeat domain 28, [RH, Score=769, Expect=0.0]; ENSG00000065413, ANKRD44, ankyrin repeat domain 44, [RH, Score=741, Expect=0.0]} {Mouse: ENSMUSG00000014496, Ankrd28, ankyrin repeat domain 28, [RH, Score=767, Expect=0.0]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=251, Expect=6e-68]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=236, Expect=3e-64]} {Smed: dd_Smed_v6_7952_0_1, dd_Smed_v6_7952_0_1, [RH, Score=521, Expect=6e-167]} {RNA1509_4645} {RNA1310_3798.1} {RNA815_1702} |
| 10. | MligTC455_18140 | 171 | 3.56 | Mlig455_033232 | Neo: - Age: Up-Down-Down Region-specific R2: 6.925 Region-enriched R2: 6.274/0.02921 |
TRPC5 | 2.398 | 0.727 | 0.962 | 0.709 | - | - | - | Mlig455_033232 {REF} {Length: 4524} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.2]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.5]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=742, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=745, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=742, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=696, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1016, Expect=0.0]} {RNA1509_34138} {RNA1310_12839} {RNA815_17637} |
| 11. | MligTC455_28695 | 95 | 1.98 | Mlig455_033490 | Neo: - Age: Up-Down-Down Region-enriched R2: 3.072/0.04773 |
PLCH2 | 2.38 | 0.702 | 0.720 | 0.958 | - | - | - | Mlig455_033490 {REF} {Length: 13918} {tRNA: Undet(NNN),pseudo, score=20.5} {Pfam: Phosphatidylinositol-specific phospholipase C, X domain [PF00388.21, score=199.7]; Phosphatidylinositol-specific phospholipase C, Y domain [PF00387.21, score=104.2]; RasGEF domain [PF00617.21, score=53.7]; Ras association (RalGDS/AF-6) domain [PF00788.25, score=44.8]; FERM central domain [PF00373.20, score=29.5]; C2 domain [PF00168.32, score=27.4]; Ankyrin repeat [PF00023.32, score=22.4]; Ankyrin repeats (3 copies) [PF12796.9, score=21.4]} {Human: ENSG00000276429, PLCH2, phospholipase C eta 2, [Score=325, Expect=2e-89]; ENSG00000149527, PLCH2, phospholipase C eta 2, [Score=325, Expect=2e-89]} {Mouse: ENSMUSG00000024998, Plce1, phospholipase C, epsilon 1, [RH, Score=281, Expect=4e-75]} {Dmel: FBgn0003416, sl, small wing, [Score=167, Expect=1e-40]} {Celegans: WBGene00004036, plc-1, 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1, [Score=248, Expect=3e-65]} {Smed: dd_Smed_v6_9716_1_1, dd_Smed_v6_9716_1_1, [RH, Score=739, Expect=0.0]} {RNA1509_26054} {RNA1310_1143.2, RNA1509_26054} {RNA1509_26054, RNA815_10233} |
| 12. | MligTC455_12700 | 10 | 0.22 | Mlig455_010549 | Neo: - Age: - |
1.997 | - | - | 0.997 | 1.000 | - | - | Mlig455_010549 {REF} {Length: 849} {Pfam: F5/8 type C domain [PF00754.27, score=28.5]} {Smed: dd_Smed_v6_83746_0_1, dd_Smed_v6_83746_0_1, [Score=54.3, Expect=2e-09]} {RNA1509_36923} {RNA1310_38503} {RNA815_10591.3} | |
| 13. | MligTC455_08518 | 6 | 0.12 | Mlig455_011791 | Neo: - Age: - |
1.993 | - | - | 0.993 | 1.000 | - | - | Mlig455_011791 {REF} {Length: 905} {Pfam: Lectin C-type domain [PF00059.23, score=27.5]} {Mouse: ENSMUSG00000008874, Clec3a, C-type lectin domain family 3, member a, [Score=46.6, Expect=6e-06]} {RNA1509_20946} {RNA1310_57972} {RNA815_39424} | |
| 14. | MligTC455_19225 | 26 | 0.54 | Mlig455_018507 | Neo: - Age: - |
SCNN1B | 1.969 | - | 0.969 | 1.000 | - | - | - | Mlig455_018507 {REF} {Length: 2590} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=142.8]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [Score=59.3, Expect=1e-08]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=60.8, Expect=1e-09]} {Smed: dd_Smed_v6_17245_0_1, dd_Smed_v6_17245_0_1, [Score=49.3, Expect=5e-06]} {RNA1509_52685} {RNA1310_32081} {RNA815_49764} |
| 15. | MligTC455_37058 | 19 | 0.4 | Mlig455_061075 | Neo: - Age: - |
1.966 | - | - | 0.970 | 0.996 | - | - | Mlig455_061075 {REF} {Length: 4598} {Pfam: IQ calmodulin-binding motif [PF00612.29, score=31.8]} {RNA1509_56135} {RNA1310_6435} {RNA815_17633} | |
| 16. | MligTC455_17266 | 62 | 1.3 | Mlig455_043650 | Neo: - Age: - |
1.961 | - | 0.968 | 0.993 | - | - | - | Mlig455_043650 {REF} {Length: 2826} {RNA1310_48878} {RNA815_25527} | |
| 17. | MligTC455_06200 | 8 | 0.17 | Mlig455_022367 | Neo: - Age: - |
1.942 | - | - | 0.993 | 0.949 | - | - | Mlig455_022367 {REF} {Length: 738} {Pfam: WSC domain [PF01822.21, score=44.0]; PAN domain [PF00024.28, score=20.8]} {RNA1310_89673} {RNA815_64813} | |
| 18. | MligTC455_35483 | 22 | 0.45 | Mlig455_056340 | Neo: - Age: - |
SETMAR | 1.939 | - | - | 0.975 | - | 0.964 | - | Mlig455_056340 {REF} {Length: 1741} {TRANSSPLICED} {Pfam: DDE superfamily endonuclease [PF13358.8, score=35.7]; HTH domain in Mos1 transposase [PF17906.3, score=29.5]; Transposase (partial DDE domain) [PF01359.20, score=28.0]; Homeodomain-like domain [PF13565.8, score=24.3]; Transposase [PF01498.20, score=23.6]; Winged helix-turn helix [PF13551.8, score=23.5]} {Human: ENSG00000170364, SETMAR, SET domain and mariner transposase fusion gene, [Score=139, Expect=2e-36]} {Smed: dd_Smed_v6_14929_0_1, dd_Smed_v6_14929_0_1, [RH, Score=66.6, Expect=1e-13]} {RNA1509_36914} {RNA1310_11258.2} {RNA815_9389} |
| 19. | MligTC455_12894 | 84 | 1.75 | Mlig455_024418, Mlig455_024572 | Neo: - Age: - Region-enriched R2: 5.211/0.02671 |
SLC46A2 | 1.936 | - | 0.953 | - | 0.983 | - | - | Mlig455_024418 {REF} {Length: 2094} {Pfam: Major Facilitator Superfamily [PF07690.18, score=30.9]} {Human: ENSG00000119457, SLC46A2, solute carrier family 46 member 2, [Score=72.4, Expect=2e-13]} {Mouse: ENSMUSG00000020829, Slc46a1, solute carrier family 46, member 1, [Score=55.1, Expect=5e-08]} {Dmel: FBgn0030576, CG15890, [Score=68.9, Expect=1e-12]} {Celegans: WBGene00012811, Y43F8A.5, [Score=65.9, Expect=9e-12]} {Smed: dd_Smed_v6_10822_0_1, dd_Smed_v6_10822_0_1, [Score=187, Expect=2e-55]} {RNA1509_40290} {RNA1310_44254} {RNA815_43004} Mlig455_024572 {REF} {Length: 1344} {Pfam: Major Facilitator Superfamily [PF07690.18, score=30.9]} {Human: ENSG00000119457, SLC46A2, solute carrier family 46 member 2, [Score=72.4, Expect=2e-13]} {Mouse: ENSMUSG00000020829, Slc46a1, solute carrier family 46, member 1, [Score=55.1, Expect=5e-08]} {Dmel: FBgn0030576, CG15890, [Score=68.9, Expect=1e-12]} {Celegans: WBGene00012811, Y43F8A.5, [Score=65.9, Expect=9e-12]} {Smed: dd_Smed_v6_10822_0_1, dd_Smed_v6_10822_0_1, [Score=187, Expect=2e-55]} {RNA1509_40290} {RNA1310_71457} {RNA815_15082} |
| 20. | MligTC455_17363 | 62 | 1.28 | Mlig455_003936 | Neo: - Age: - |
1.931 | - | 0.953 | 0.978 | - | - | - | Mlig455_003936 {REF} {Length: 1252} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=45.9]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=26.4]} {RNA1310_47889} {RNA815_24646} | |
| 21. | MligTC455_50643 | 38 | 0.8 | Mlig455_007952, Mlig455_008053 | Neo: - Age: - |
VSX1 | 1.924 | - | 0.924 | 1.000 | - | - | - | Mlig455_007952 {REF} {Length: 1358} {Pfam: Homeodomain [PF00046.31, score=79.6]} {Human: ENSG00000100987, VSX1, visual system homeobox 1, [RH, Score=197, Expect=4e-60]; ENSG00000119614, VSX2, visual system homeobox 2, [RH, Score=196, Expect=2e-59]} {Mouse: ENSMUSG00000021239, Vsx2, visual system homeobox 2, [RH, Score=196, Expect=6e-60]; ENSMUSG00000033080, Vsx1, visual system homeobox 1, [RH, Score=195, Expect=2e-59]} {Dmel: FBgn0263512, Vsx2, Visual system homeobox 2, [RH, Score=204, Expect=3e-60]} {Celegans: WBGene00000435, ceh-10, Homeobox protein ceh-10, [RH, Score=204, Expect=2e-63]} {Smed: dd_Smed_v6_19286_0_1, dd_Smed_v6_19286_0_1, [RH, Score=211, Expect=2e-66]} {RNA1310_76393} {RNA815_51313} Mlig455_008053 {REF} {Length: 2271} {RNA1310_76393} {RNA815_51313} |
| 22. | MligTC455_40355 | 10 | 0.21 | Mlig455_069630 | Neo: - Age: - |
KREMEN1 | 1.909 | - | - | 1.000 | 0.909 | - | - | Mlig455_069630 {REF} {Length: 920} {Pfam: WSC domain [PF01822.21, score=52.7]; PAN domain [PF00024.28, score=24.9]} {Human: ENSG00000183762, KREMEN1, kringle containing transmembrane protein 1, [Score=53.9, Expect=8e-08]} {Mouse: ENSMUSG00000020393, Kremen1, kringle containing transmembrane protein 1, [Score=56.6, Expect=9e-09]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=48.5, Expect=3e-06]} {RNA1509_46267} {RNA1310_46146} {RNA815_32275.1} |
| 23. | MligTC455_08763 | 20 | 0.41 | Mlig455_061186 | Neo: - Age: - |
1.901 | - | 0.971 | 0.930 | - | - | - | Mlig455_061186 {REF} {Length: 1077} {Smed: dd_Smed_v6_13791_0_1, dd_Smed_v6_13791_0_1, [Score=96.3, Expect=3e-24]} {RNA1310_122132} | |
| 24. | MligTC455_15229 | 6 | 0.12 | Mlig455_032752 | Neo: - Age: - |
1.901 | - | - | 0.901 | 1.000 | - | - | Mlig455_032752 {REF} {Length: 1841} {Pfam: F5/8 type C domain [PF00754.27, score=51.0]; PAN-like domain [PF08277.14, score=26.2]} {Smed: dd_Smed_v6_1477_1_1, dd_Smed_v6_1477_1_1, [RH, Score=51.2, Expect=6e-08]} {RNA1509_36923} {RNA1310_46041} {RNA815_10591.1} | |
| 25. | MligTC455_09874 | 31 | 0.65 | Mlig455_045071 | Neo: - Age: - |
DOC2A | 1.891 | - | 0.971 | 0.920 | - | - | - | Mlig455_045071 {REF} {Length: 1760} {Pfam: C2 domain [PF00168.32, score=55.9]} {Human: ENSG00000149927, DOC2A, double C2 domain alpha, [Score=55.8, Expect=7e-08]} {Mouse: ENSMUSG00000052301, Doc2a, double C2, alpha, [Score=55.5, Expect=7e-08]} {Celegans: WBGene00004923, snt-3, SyNapTotagmin, [Score=70.5, Expect=2e-13]} {Smed: dd_Smed_v6_16731_0_1, dd_Smed_v6_16731_0_1, [Score=112, Expect=7e-27]} {RNA1310_36283} {RNA815_40844} |
| 26. | MligTC455_37701 | 47 | 0.98 | Mlig455_029831 | Neo: - Age: - Region-enriched R2: 8.298/0.02665 |
1.891 | - | 0.939 | 0.952 | - | - | - | Mlig455_029831 {REF} {Length: 724} {RNA1310_73844} | |
| 27. | MligTC455_24270 | 71 | 1.47 | Mlig455_005120 | Neo: - Age: - |
CHRNA7 | 1.884 | - | 0.971 | 0.913 | - | - | - | Mlig455_005120 {REF} {Length: 1530} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=115.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=66.6]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=148, Expect=4e-39]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=147, Expect=5e-39]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=145, Expect=4e-38]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=146, Expect=2e-38]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=140, Expect=1e-36]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=135, Expect=5e-34]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=134, Expect=9e-35]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=133, Expect=4e-34]} {RNA1509_43533} {RNA1310_20839.2} {RNA815_22406} |
| 28. | MligTC455_54282 | 74 | 1.54 | Mlig455_020191 | Neo: - Age: - |
1.884 | - | 0.908 | 0.976 | - | - | - | Mlig455_020191 {REF} {Length: 937} {RNA1509_48973} {RNA1310_40738.2} {RNA815_31898} | |
| 29. | MligTC455_17479 | 32 | 0.66 | Mlig455_032081, Mlig455_070278 | Neo: - Age: logFC(26M/2M)=-0.516 |
CHRNA3 | 1.879 | - | 0.962 | - | 0.917 | - | - | Mlig455_032081 {REF} {Length: 2787} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=230.7]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=221.4]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=368, Expect=1e-121]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=366, Expect=5e-121]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=378, Expect=6e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=361, Expect=3e-119]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=461, Expect=3e-158]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=381, Expect=3e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=614, Expect=0.0]} {RNA1509_28642} {RNA1310_34709} {RNA815_44960} Mlig455_070278 {REF} {Length: 2270} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=232.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=221.2]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=369, Expect=7e-122]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=366, Expect=4e-121]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=378, Expect=9e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=362, Expect=1e-119]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=461, Expect=3e-158]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=382, Expect=2e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=616, Expect=0.0]} {RNA1509_16247} {RNA1310_34709} {RNA815_44960} |
| 30. | MligTC455_23287 | 106 | 2.21 | Mlig455_052789 | Neo: - Age: Up-Down-Down Region-enriched R2: 6.273/0.00029 |
1.878 | - | 0.883 | 0.995 | - | - | - | Mlig455_052789 {REF} {Length: 2348} {RNA1310_41474} {RNA815_41242} | |
| 31. | MligTC455_30140 | 22 | 0.46 | Mlig455_055220 | Neo: - Age: - |
GALR2 | 1.874 | - | - | 0.958 | 0.916 | - | - | Mlig455_055220 {REF} {Length: 2272} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=169.9]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=36.8]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.2]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=21.8]} {Human: ENSG00000182687, GALR2, galanin receptor 2, [RH, Score=167, Expect=4e-47]} {Mouse: ENSMUSG00000020793, Galr2, galanin receptor 2, [RH, Score=164, Expect=2e-46]} {Dmel: FBgn0036789, AstC-R2, Allatostatin C receptor 2, [RH, Score=133, Expect=8e-34]} {Celegans: WBGene00013974, npr-9, Galanin-like G-protein coupled receptor npr-9, [Score=115, Expect=2e-28]} {Smed: dd_Smed_v6_10325_0_1, dd_Smed_v6_10325_0_1, [Score=142, Expect=6e-38]} {RNA1310_26096} |
| 32. | MligTC455_40199 | 64 | 1.33 | Mlig455_026444, Mlig455_026477 | Neo: - Age: - |
ASIC4 | 1.872 | - | - | 0.872 | 1.000 | - | - | Mlig455_026444 {REF} {Length: 2570} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=204.0]} {Human: ENSG00000072182, ASIC4, acid sensing ion channel subunit family member 4, [Score=57.4, Expect=7e-08]} {Mouse: ENSMUSG00000033007, Asic4, acid-sensing (proton-gated) ion channel family member 4, [Score=53.9, Expect=5e-07]; ENSMUSG00000038276, Asic3, acid-sensing (proton-gated) ion channel 3, [Score=52.4, Expect=1e-06]} {Celegans: WBGene00003174, mec-10, Degenerin mec-10, [Score=69.7, Expect=5e-12]} {Smed: dd_Smed_v6_12878_0_1, dd_Smed_v6_12878_0_1, [Score=119, Expect=6e-28]} {RNA1310_21223} {RNA815_27174} Mlig455_026477 {REF} {Length: 2402} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=160.5]} {Human: ENSG00000072182, ASIC4, acid sensing ion channel subunit family member 4, [Score=57.0, Expect=8e-08]} {Mouse: ENSMUSG00000033007, Asic4, acid-sensing (proton-gated) ion channel family member 4, [Score=53.9, Expect=5e-07]} {Celegans: WBGene00003174, mec-10, Degenerin mec-10, [Score=69.3, Expect=5e-12]} {Smed: dd_Smed_v6_12878_0_1, dd_Smed_v6_12878_0_1, [Score=93.6, Expect=9e-20]} {RNA1310_21223} {RNA815_27174} |
| 33. | MligTC455_49922 | 36 | 0.76 | Mlig455_049338 | Neo: - Age: Down-Down-Up Region-enriched R2: 7.622/0.00496 |
1.867 | - | 0.967 | 0.900 | - | - | - | Mlig455_049338 {REF} {Length: 971} {RNA1310_37449} {RNA815_3585} | |
| 34. | MligTC455_14372 | 41 | 0.84 | Mlig455_048281 | Neo: - Age: - |
1.864 | - | 0.903 | - | 0.961 | - | - | Mlig455_048281 {REF} {Length: 1396} {Pfam: Sulfotransferase domain [PF19798.1, score=52.4]} {RNA1310_42847} {RNA815_35707} | |
| 35. | MligTC455_35503 | 32 | 0.66 | Mlig455_009758, Mlig455_070115 | Neo: - Age: - |
HMX3 | 1.852 | - | 0.881 | 0.971 | - | - | - | Mlig455_009758 {REF} {Length: 2090} {Pfam: Homeodomain [PF00046.31, score=72.3]} {Human: ENSG00000188620, HMX3, H6 family homeobox 3, [RH, Score=163, Expect=1e-44]} {Mouse: ENSMUSG00000040148, Hmx3, H6 homeobox 3, [RH, Score=162, Expect=2e-44]; ENSMUSG00000067438, Hmx1, H6 homeobox 1, [RH, Score=155, Expect=4e-42]} {Dmel: FBgn0011758, B-H1, BarH1, [Score=102, Expect=1e-22]} {Celegans: WBGene00003377, mls-2, Mesodermal Lineage Specification, [RH, Score=113, Expect=2e-27]} {Smed: dd_Smed_v6_52497_0_1, dd_Smed_v6_52497_0_1, [RH, Score=150, Expect=4e-42]} Mlig455_070115 {REF} {Length: 2868} {Pfam: Homeodomain [PF00046.31, score=72.2]} {Human: ENSG00000188620, HMX3, H6 family homeobox 3, [RH, Score=163, Expect=6e-45]} {Mouse: ENSMUSG00000040148, Hmx3, H6 homeobox 3, [RH, Score=162, Expect=1e-44]; ENSMUSG00000067438, Hmx1, H6 homeobox 1, [RH, Score=155, Expect=3e-42]} {Dmel: FBgn0011758, B-H1, BarH1, [Score=102, Expect=9e-23]} {Celegans: WBGene00003377, mls-2, Mesodermal Lineage Specification, [RH, Score=113, Expect=1e-27]} {Smed: dd_Smed_v6_52497_0_1, dd_Smed_v6_52497_0_1, [RH, Score=151, Expect=2e-42]} {RNA1310_148861} |
| 36. | MligTC455_17068 | 180 | 3.74 | Mlig455_055276 | Neo: - Age: - |
ADCY5 | 1.829 | - | - | - | 0.986 | - | 0.843 | Mlig455_055276 {REF} {Length: 1899} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=170.8]} {Human: ENSG00000173175, ADCY5, adenylate cyclase 5, [Score=244, Expect=2e-70]; ENSG00000174233, ADCY6, adenylate cyclase 6, [Score=240, Expect=2e-68]} {Mouse: ENSMUSG00000022840, Adcy5, adenylate cyclase 5, [Score=249, Expect=2e-71]; ENSMUSG00000022994, Adcy6, adenylate cyclase 6, [Score=248, Expect=3e-71]} {Dmel: FBgn0263131, CG43373, [Score=238, Expect=8e-68]} {Celegans: WBGene00000071, acy-4, Adenylyl CYclase, [Score=202, Expect=5e-56]} {Smed: dd_Smed_v6_2998_0_1, dd_Smed_v6_2998_0_1, [Score=166, Expect=1e-43]} {RNA1310_34165} {RNA815_28128} |
| 37. | MligTC455_19412 | 42 | 0.88 | Mlig455_047997 | Neo: - Age: - |
1.827 | - | 0.849 | 0.978 | - | - | - | Mlig455_047997 {REF} {Length: 701} {RNA1310_53549} {RNA815_27051} | |
| 38. | MligTC455_52527 | 28 | 0.58 | Mlig455_025836 | Neo: - Age: - |
FLVCR2 | 1.827 | - | 0.965 | 0.862 | - | - | - | Mlig455_025836 {REF} {Length: 2177} {TRANSSPLICED} {Pfam: Major Facilitator Superfamily [PF07690.18, score=81.4]; Sugar (and other) transporter [PF00083.26, score=18.7]} {Human: ENSG00000119686, FLVCR2, feline leukemia virus subgroup C cellular receptor family member 2, [RH, Score=364, Expect=5e-119]} {Mouse: ENSMUSG00000034258, Flvcr2, feline leukemia virus subgroup C cellular receptor 2, [RH, Score=367, Expect=3e-120]} {Dmel: FBgn0033196, CG1358, [RH, Score=350, Expect=1e-114]} {Celegans: WBGene00015632, C09D4.1, Uncharacterized MFS-type transporter C09D4.1, [RH, Score=358, Expect=1e-116]} {Smed: dd_Smed_v6_7578_0_1, dd_Smed_v6_7578_0_1, [Score=335, Expect=3e-109]} {RNA1509_31725} {RNA1310_8852.1} {RNA815_14234} |
| 39. | MligTC455_16846 | 158 | 3.3 | Mlig455_051873 | Neo: - Age: Down-Up-Up Region-enriched R2: 5.265/0.00110 |
PRSS33 | 1.825 | - | 0.854 | 0.971 | - | - | - | Mlig455_051873 {REF} {Length: 1386} {Pfam: Trypsin [PF00089.28, score=189.9]; Domain of unknown function (DUF1986) [PF09342.13, score=27.5]; Trypsin-like peptidase domain [PF13365.8, score=26.9]} {Human: ENSG00000103355, PRSS33, serine protease 33, [Score=159, Expect=4e-46]} {Mouse: ENSMUSG00000016942, Tmprss6, transmembrane serine protease 6, [Score=154, Expect=4e-41]; ENSMUSG00000037129, Tmprss13, transmembrane protease, serine 13, [Score=150, Expect=2e-40]; ENSMUSG00000059406, Tmprss9, transmembrane protease, serine 9, [Score=148, Expect=6e-39]} {Dmel: FBgn0036287, CG10663, [Score=146, Expect=1e-38]} {Celegans: WBGene00006620, svh-1, HGF/MSP/plasminogen-like protein, [Score=125, Expect=2e-31]} {Smed: dd_Smed_v6_10267_0_1, dd_Smed_v6_10267_0_1, [Score=178, Expect=3e-53]} {RNA1509_26566} {RNA1310_23561} {RNA815_9840} |
| 40. | MligTC455_52480 | 25 | 0.51 | Mlig455_040937 | Neo: - Age: - |
1.825 | - | 0.826 | 0.999 | - | - | - | Mlig455_040937 {REF} {Length: 2050} {RNA1310_86606} {RNA815_50003.1} | |
| 41. | MligTC455_24492 | 29 | 0.59 | Mlig455_031458 | Neo: - Age: - |
1.817 | - | - | 0.994 | - | - | 0.823 | Mlig455_031458 {REF} {Length: 3309} {Smed: dd_Smed_v6_6746_0_1, dd_Smed_v6_6746_0_1, [Score=57.8, Expect=1e-08]} {RNA1310_19918} {RNA815_19102} | |
| 42. | MligTC455_34655 | 89 | 1.86 | Mlig455_058020, Mlig455_058176 | Neo: - Age: - Region-enriched R2: 5.798/0.00826 |
PPEF1 | 1.815 | 0.855 | - | 0.960 | - | - | - | Mlig455_058020 {REF} {Length: 3007} {Pfam: Calcineurin-like phosphoesterase [PF00149.30, score=84.9]; EF-hand domain pair [PF13499.8, score=77.8]; EF hand [PF00036.34, score=66.0]; EF-hand domain pair [PF13833.8, score=52.1]; EF-hand domain [PF13405.8, score=48.4]; EF hand [PF13202.8, score=38.2]; PPP5 TPR repeat region [PF08321.14, score=37.0]; EF-hand domain [PF14658.8, score=23.0]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=20.4]} {Human: ENSG00000086717, PPEF1, protein phosphatase with EF-hand domain 1, [Score=416, Expect=2e-138]} {Mouse: ENSMUSG00000062168, Ppef1, protein phosphatase with EF hand calcium-binding domain 1, [Score=413, Expect=9e-138]} {Dmel: FBgn0265959, rdgC, retinal degeneration C, [Score=404, Expect=3e-134]} {Celegans: WBGene00003969, pef-1, Serine/threonine-protein phosphatase with EF-hands pef-1, [Score=455, Expect=2e-155]} {Smed: dd_Smed_v6_11874_0_2, dd_Smed_v6_11874_0_2, [Score=516, Expect=2e-178]} {RNA1509_3508} {RNA1310_10928.2} {RNA815_11707} Mlig455_058176 {REF} {Length: 3371} {Pfam: Calcineurin-like phosphoesterase [PF00149.30, score=102.6]; EF-hand domain pair [PF13499.8, score=72.6]; EF hand [PF00036.34, score=64.2]; EF-hand domain pair [PF13833.8, score=51.3]; EF-hand domain [PF13405.8, score=46.1]; EF hand [PF13202.8, score=36.7]; PPP5 TPR repeat region [PF08321.14, score=36.6]; EF-hand domain [PF14658.8, score=26.5]; IQ calmodulin-binding motif [PF00612.29, score=21.3]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=19.8]} {Human: ENSG00000086717, PPEF1, protein phosphatase with EF-hand domain 1, [RH, Score=546, Expect=0.0]} {Mouse: ENSMUSG00000062168, Ppef1, protein phosphatase with EF hand calcium-binding domain 1, [Score=520, Expect=3e-177]} {Dmel: FBgn0265959, rdgC, retinal degeneration C, [Score=529, Expect=2e-180]} {Celegans: WBGene00003969, pef-1, Serine/threonine-protein phosphatase with EF-hands pef-1, [Score=598, Expect=0.0]} {Smed: dd_Smed_v6_11874_0_1, dd_Smed_v6_11874_0_1, [Score=671, Expect=0.0]} {RNA1509_3508} {RNA1310_10928.2} {RNA815_11707} |
| 43. | MligTC455_12978 | 63 | 1.31 | Mlig455_023948 | Neo: - Age: - |
1.812 | - | 0.969 | - | - | 0.843 | - | Mlig455_023948 {REF} {Length: 2929} {RNA1310_80095.1} | |
| 44. | MligTC455_16248 | 132 | 2.74 | Mlig455_038325, Mlig455_050222, Mlig455_050231 | Neo: - Age: - |
CHRNA3 | 1.812 | - | 0.971 | 0.841 | - | - | - | Mlig455_038325 {REF} {Length: 1078} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=200.0]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=192, Expect=4e-57]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=194, Expect=7e-58]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=190, Expect=1e-56]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=206, Expect=1e-62]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=186, Expect=4e-55]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=216, Expect=5e-67]} {RNA1310_44575} {RNA815_22042} Mlig455_050222 {REF} {Length: 2164} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=202.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=197.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=348, Expect=5e-114]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=335, Expect=4e-109]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=348, Expect=2e-114]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=343, Expect=2e-112]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=335, Expect=5e-109]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=397, Expect=1e-133]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=338, Expect=2e-110]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=489, Expect=5e-170]} {RNA1310_44575} {RNA815_22042} Mlig455_050231 {REF} {Length: 2219} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=203.3]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=143.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=304, Expect=5e-99]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=299, Expect=8e-97]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=293, Expect=2e-94]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=290, Expect=7e-92]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=302, Expect=3e-98]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=296, Expect=3e-96]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=291, Expect=5e-94]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=352, Expect=8e-117]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=303, Expect=5e-99]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=424, Expect=2e-146]} {RNA1310_44575} {RNA815_22042} |
| 45. | MligTC455_34656 | 48 | 1 | Mlig455_058210 | Neo: Irradiation Age: Up-Down-Down, logFC(26M/2M)=-0.537 Region-enriched R2: 5.874/0.03747 |
PPEF1 | 1.811 | 0.855 | - | 0.956 | - | - | - | Mlig455_058210 {REF} {Length: 2937} {Pfam: Calcineurin-like phosphoesterase [PF00149.30, score=90.9]; EF-hand domain pair [PF13499.8, score=63.3]; EF hand [PF00036.34, score=53.9]; PPP5 TPR repeat region [PF08321.14, score=45.9]; EF-hand domain pair [PF13833.8, score=45.7]; EF-hand domain [PF13405.8, score=43.1]; EF hand [PF13202.8, score=41.7]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=20.2]} {Human: ENSG00000086717, PPEF1, protein phosphatase with EF-hand domain 1, [Score=533, Expect=0.0]} {Mouse: ENSMUSG00000062168, Ppef1, protein phosphatase with EF hand calcium-binding domain 1, [Score=512, Expect=1e-174]} {Dmel: FBgn0265959, rdgC, retinal degeneration C, [Score=489, Expect=6e-166]} {Celegans: WBGene00003969, pef-1, Serine/threonine-protein phosphatase with EF-hands pef-1, [Score=563, Expect=0.0]} {Smed: dd_Smed_v6_11874_0_1, dd_Smed_v6_11874_0_1, [Score=642, Expect=0.0]} {RNA1509_3508} {RNA1310_11714.1} {RNA815_4130} |
| 46. | MligTC455_53658 | 41 | 0.86 | Mlig455_070698 | Neo: - Age: Up-Down-Down Region-enriched R2: 9.084/0.01491 |
1.81 | - | 0.968 | 0.842 | - | - | - | Mlig455_070698 {REF} {Length: 1026} {RNA1509_40972} {RNA1310_35649.1} {RNA815_17004} | |
| 47. | MligTC455_12525 | 11 | 0.23 | Mlig455_067862 | Neo: - Age: - |
1.808 | - | - | 0.808 | 1.000 | - | - | Mlig455_067862 {REF} {Length: 1730} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=44.0]; TcdA/TcdB catalytic glycosyltransferase domain [PF12919.9, score=18.1]} {Smed: dd_Smed_v6_13661_0_2, dd_Smed_v6_13661_0_2, [Score=80.9, Expect=3e-17]} {RNA1509_20770} {RNA1310_58410} {RNA815_35907} | |
| 48. | MligTC455_44189 | 30 | 0.63 | Mlig455_020227 | Neo: - Age: - |
APLNR | 1.798 | - | 0.808 | - | 0.990 | - | - | Mlig455_020227 {REF} {Length: 2245} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=51.2]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=35.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=21.0]} {Human: ENSG00000134817, APLNR, apelin receptor, [Score=54.3, Expect=2e-07]} {Mouse: ENSMUSG00000037014, Sstr4, somatostatin receptor 4, [Score=54.7, Expect=1e-07]} {Dmel: FBgn0035385, FMRFaR, FMRFamide Receptor, [Score=94.0, Expect=4e-20]} {Celegans: WBGene00020586, frpr-18, FLP-2 receptor; FMRFamide Peptide Receptor family, [Score=87.0, Expect=4e-18]} {Smed: dd_Smed_v6_31203_0_1, dd_Smed_v6_31203_0_1, [Score=167, Expect=2e-46]} {RNA1310_43286} {RNA815_36082} |
| 49. | MligTC455_43434 | 12 | 0.25 | Mlig455_049038 | Neo: - Age: - |
1.796 | - | - | 0.987 | 0.809 | - | - | Mlig455_049038 {REF} {Length: 3155} {Pfam: Peptidase family M13 [PF05649.15, score=24.5]} | |
| 50. | MligTC455_20088 | 39 | 0.81 | Mlig455_017821 | Neo: - Age: Up-Down-Down |
GLIPR1 | 1.795 | - | - | 0.830 | 0.965 | - | - | Mlig455_017821 {REF} {Length: 2083} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=62.2]} {Human: ENSG00000139278, GLIPR1, GLI pathogenesis related 1, [Score=89.4, Expect=2e-19]} {Mouse: ENSMUSG00000025431, Crisp1, cysteine-rich secretory protein 1, [RH, Score=84.3, Expect=5e-18]} {Dmel: FBgn0038126, CG8483, [Score=54.3, Expect=1e-07]} {Celegans: WBGene00003055, lon-1, LONg, [Score=78.6, Expect=5e-16]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [RH, Score=143, Expect=7e-37]} {RNA1310_43937.1} {RNA815_38891} |
| 51. | MligTC455_47675 | 2101 | 43.77 | Mlig455_061675, Mlig455_063136 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.812 Region-specific R2: 4.381 Region-enriched R2: 4.099/0.00000 |
CLEC18C | 1.795 | - | 0.840 | 0.955 | - | - | - | Mlig455_061675 {REF} {Length: 2392} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=60.3]} {Human: ENSG00000157335, CLEC18C, C-type lectin domain family 18 member C, [RH, Score=75.5, Expect=1e-13]; ENSG00000140839, CLEC18B, C-type lectin domain family 18 member B, [RH, Score=75.1, Expect=1e-13]} {Mouse: ENSMUSG00000020213, Glipr1l1, GLI pathogenesis-related 1 like 1, [Score=77.8, Expect=1e-15]; ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=75.9, Expect=7e-15]} {Celegans: WBGene00003055, lon-1, LONg, [Score=62.8, Expect=2e-10]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [Score=134, Expect=5e-33]} {RNA1509_48080} {RNA1310_16102.1} {RNA815_9265} Mlig455_063136 {REF} {Length: 2649} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=60.7]} {Human: ENSG00000157335, CLEC18C, C-type lectin domain family 18 member C, [RH, Score=77.8, Expect=1e-14]; ENSG00000140839, CLEC18B, C-type lectin domain family 18 member B, [RH, Score=77.4, Expect=1e-14]; ENSG00000157322, CLEC18A, C-type lectin domain family 18 member A, [RH, Score=77.0, Expect=2e-14]} {Mouse: ENSMUSG00000020213, Glipr1l1, GLI pathogenesis-related 1 like 1, [Score=78.2, Expect=5e-16]; ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=76.3, Expect=3e-14]} {Celegans: WBGene00003055, lon-1, LONg, [Score=63.5, Expect=6e-11]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [RH, Score=136, Expect=3e-34]} {RNA1509_48080} {RNA1310_16102.1} {RNA815_9265} |
| 52. | MligTC455_15890 | 18 | 0.38 | Mlig455_059636 | Neo: - Age: - |
CD209 | 1.79 | - | - | 0.836 | 0.954 | - | - | Mlig455_059636 {REF} {Length: 1223} {Pfam: Lectin C-type domain [PF00059.23, score=29.7]} {Human: ENSG00000090659, CD209, CD209 molecule, [Score=49.3, Expect=2e-06]} {Dmel: FBgn0040096, lectin-33A, [Score=48.9, Expect=6e-07]} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=64.7, Expect=2e-12]} {RNA1509_20946} {RNA1310_53178} {RNA815_42043} |
| 53. | MligTC455_18506 | 59 | 1.23 | Mlig455_038054 | Neo: - Age: Down-Up-Down |
SP9 | 1.789 | - | 0.805 | 0.984 | - | - | - | Mlig455_038054 {REF} {Length: 3168} {Pfam: Zinc-finger double domain [PF13465.8, score=49.0]; Zinc finger, C2H2 type [PF00096.28, score=40.9]; C2H2-type zinc finger [PF13894.8, score=26.8]} {Human: ENSG00000217236, SP9, Sp9 transcription factor, [RH, Score=202, Expect=4e-59]; ENSG00000164651, SP8, Sp8 transcription factor, [RH, Score=202, Expect=5e-59]} {Mouse: ENSMUSG00000068859, Sp9, trans-acting transcription factor 9, [RH, Score=202, Expect=3e-59]; ENSMUSG00000048562, Sp8, trans-acting transcription factor 8, [RH, Score=201, Expect=9e-59]} {Dmel: FBgn0020378, Sp1, [RH, Score=198, Expect=6e-56]} {Celegans: WBGene00012735, sptf-3, SP (Specificity Protein) Transcription Factor, [Score=137, Expect=1e-35]} {Smed: dd_Smed_v6_17385_0_1, dd_Smed_v6_17385_0_1, [RH, Score=160, Expect=5e-46]} {RNA1310_42373} |
| 54. | MligTC455_17744 | 152 | 3.16 | Mlig455_004612 | Neo: - Age: logFC(26M/2M)=-0.493 Region-enriched R2: 4.143/0.01116 |
INTS2 | 1.789 | - | - | 0.959 | - | - | 0.830 | Mlig455_004612 {REF} {Length: 5765} {Pfam: Integrator complex subunit 2 [PF14750.8, score=434.4]} {Human: ENSG00000108506, INTS2, integrator complex subunit 2, [Score=168, Expect=2e-41]} {Mouse: ENSMUSG00000018068, Ints2, integrator complex subunit 2, [Score=168, Expect=1e-41]} {Dmel: FBgn0030858, IntS2, Integrator 2, [Score=162, Expect=3e-40]} {Smed: dd_Smed_v6_7197_0_2, dd_Smed_v6_7197_0_2, [Score=187, Expect=6e-48]} {RNA1509_16977} {RNA1310_2572} {RNA815_13711} |
| 55. | MligTC455_53586 | 32 | 0.66 | Mlig455_061060 | Neo: - Age: - |
1.788 | - | 0.953 | 0.835 | - | - | - | Mlig455_061060 {REF} {Length: 1466} {RNA1310_93934} {RNA815_37442} | |
| 56. | MligTC455_17562 | 108 | 2.25 | Mlig455_022496 | Neo: - Age: - |
NECAB3 | 1.785 | - | 0.830 | 0.955 | - | - | - | Mlig455_022496 {REF} {Length: 1499} {Pfam: EF hand [PF00036.34, score=34.0]; EF-hand domain [PF13405.8, score=33.4]; EF-hand domain pair [PF13833.8, score=29.2]; EF-hand domain pair [PF13499.8, score=28.3]; Antibiotic biosynthesis monooxygenase [PF03992.18, score=22.0]; EF hand [PF13202.8, score=21.3]} {Human: ENSG00000125967, NECAB3, N-terminal EF-hand calcium binding protein 3, [RH, Score=189, Expect=7e-57]; ENSG00000123119, NECAB1, N-terminal EF-hand calcium binding protein 1, [RH, Score=186, Expect=1e-55]} {Mouse: ENSMUSG00000040536, Necab1, N-terminal EF-hand calcium binding protein 1, [RH, Score=191, Expect=7e-58]; ENSMUSG00000027489, Necab3, N-terminal EF-hand calcium binding protein 3, [RH, Score=191, Expect=9e-58]} {RNA1509_46831} {RNA1310_24461} {RNA815_25216} |
| 57. | MligTC455_06061 | 7 | 0.14 | Mlig455_003828, Mlig455_033255 | Neo: - Age: - |
PARP4 | 1.783 | - | - | 0.790 | - | - | 0.993 | Mlig455_003828 {REF} {Length: 1134} {Pfam: Poly(ADP-ribose) polymerase catalytic domain [PF00644.22, score=77.7]} {Human: ENSG00000102699, PARP4, poly(ADP-ribose) polymerase family member 4, [Score=64.3, Expect=2e-11]} {Mouse: ENSMUSG00000054509, Parp4, poly (ADP-ribose) polymerase family, member 4, [Score=66.2, Expect=4e-12]} {Dmel: FBgn0027508, Tnks, tankyrase, [Score=50.8, Expect=3e-07]} {RNA1509_37076} {RNA1310_33065.1} {RNA815_15461} Mlig455_033255 {REF} {Length: 1138} {Pfam: Poly(ADP-ribose) polymerase catalytic domain [PF00644.22, score=77.7]} {Human: ENSG00000102699, PARP4, poly(ADP-ribose) polymerase family member 4, [Score=64.3, Expect=2e-11]} {Mouse: ENSMUSG00000054509, Parp4, poly (ADP-ribose) polymerase family, member 4, [Score=66.2, Expect=4e-12]} {Dmel: FBgn0027508, Tnks, tankyrase, [Score=50.8, Expect=3e-07]} {RNA1509_23765, RNA1509_37076} {RNA1310_33065.1, RNA1509_23765, RNA1509_37076} {RNA1509_23765, RNA1509_37076, RNA815_15461} |
| 58. | MligTC455_18309 | 17 | 0.35 | Mlig455_056133 | Neo: - Age: - |
1.782 | 0.803 | - | 0.979 | - | - | - | Mlig455_056133 {REF} {Length: 1429} {RNA1310_65004} | |
| 59. | MligTC455_20532 | 63 | 1.32 | Mlig455_029971 | Neo: - Age: - |
1.777 | - | - | 0.788 | 0.989 | - | - | Mlig455_029971 {REF} {Length: 1702} {Pfam: UPF0489 domain [PF12640.9, score=20.3]} {RNA1509_3030} {RNA1310_35103} {RNA815_26539} | |
| 60. | MligTC455_13259 | 11 | 0.23 | Mlig455_026238, Mlig455_042504 | Neo: - Age: - |
KREMEN1 | 1.769 | - | - | 0.809 | 0.960 | - | - | Mlig455_026238 {REF} {Length: 468} Mlig455_042504 {REF} {Length: 806} {Pfam: WSC domain [PF01822.21, score=46.2]} {Human: ENSG00000183762, KREMEN1, kringle containing transmembrane protein 1, [Score=51.6, Expect=3e-07]} {Mouse: ENSMUSG00000020393, Kremen1, kringle containing transmembrane protein 1, [Score=49.3, Expect=9e-07]} {RNA1310_57841} {RNA815_19006.2} |
| 61. | MligTC455_13434 | 15 | 0.3 | Mlig455_025922 | Neo: - Age: - |
1.766 | - | 0.767 | 0.999 | - | - | - | Mlig455_025922 {REF} {Length: 1467} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=36.3]} {RNA1310_51631} {RNA815_34338} | |
| 62. | MligTC455_42256 | 163 | 3.39 | Mlig455_054046 | Neo: - Age: Down-Up-Up |
LDB2 | 1.765 | - | 0.774 | 0.991 | - | - | - | Mlig455_054046 {REF} {Length: 2089} {Pfam: LIM-domain binding protein [PF01803.18, score=164.3]; LIM interaction domain (LID) [PF17916.3, score=55.5]} {Human: ENSG00000169744, LDB2, LIM domain binding 2, [RH, Score=390, Expect=4e-132]} {Mouse: ENSMUSG00000039706, Ldb2, LIM domain binding 2, [RH, Score=388, Expect=3e-131]} {Dmel: FBgn0013764, Chi, Chip, [RH, Score=332, Expect=9e-107]} {Celegans: WBGene00002261, ldb-1, F58A3.1a; LIM Domain Binding protein, [RH, Score=155, Expect=2e-40]} {Smed: dd_Smed_v6_3678_0_1, dd_Smed_v6_3678_0_1, [Score=321, Expect=1e-102]} {RNA1310_27326} {RNA815_22302} |
| 63. | MligTC455_15745 | 27 | 0.56 | Mlig455_040119, Mlig455_067332 | Neo: - Age: - |
ANGPTL2 | 1.761 | - | 0.805 | 0.956 | - | - | - | Mlig455_040119 {REF} {Length: 1066} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=123.8]; PAN domain [PF00024.28, score=20.3]} {Human: ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=102, Expect=5e-24]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=100, Expect=2e-23]; ENSG00000116147, TNR, tenascin R, [Score=100, Expect=2e-23]; ENSG00000120332, TNN, tenascin N, [Score=97.8, Expect=3e-22]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [Score=102, Expect=8e-25]; ENSMUSG00000015829, Tnr, tenascin R, [Score=101, Expect=1e-23]; ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=100, Expect=8e-24]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=100, Expect=1e-23]} {Dmel: FBgn0050280, CG30280, [Score=104, Expect=2e-26]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=105, Expect=2e-25]} {RNA1509_58115} {RNA1310_32877} {RNA815_17241} Mlig455_067332 {REF} {Length: 1104} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=125.5]; PAN domain [PF00024.28, score=19.2]} {Human: ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=104, Expect=1e-24]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=103, Expect=3e-24]; ENSG00000116147, TNR, tenascin R, [Score=101, Expect=2e-23]} {Mouse: ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=103, Expect=2e-24]; ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=103, Expect=1e-24]; ENSMUSG00000026938, Fcna, ficolin A, [Score=102, Expect=7e-25]; ENSMUSG00000015829, Tnr, tenascin R, [Score=101, Expect=1e-23]} {Dmel: FBgn0050280, CG30280, [Score=107, Expect=2e-27]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=107, Expect=4e-26]} {RNA1509_58115} {RNA1310_32877} {RNA815_17241} |
| 64. | MligTC455_51872 | 25 | 0.51 | Mlig455_002762, Mlig455_063364 | Neo: - Age: - |
1.752 | - | - | 0.994 | 0.758 | - | - | Mlig455_002762 {REF} {Length: 1093} {RNA1310_80259} {RNA815_47710} Mlig455_063364 {REF} {Length: 1091} {RNA1310_80259} {RNA815_47710} |
|
| 65. | MligTC455_15184 | 33 | 0.69 | Mlig455_065087 | Neo: - Age: - |
1.75 | 0.754 | - | 0.996 | - | - | - | Mlig455_065087 {REF} {Length: 2555} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=183.3]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=48.5, Expect=1e-05]} {Celegans: WBGene00009073, delm-1, DEgenerin Linked to Mechanosensation, [Score=68.2, Expect=1e-11]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [RH, Score=125, Expect=3e-30]} {RNA1310_11413} {RNA815_11497} | |
| 66. | MligTC455_43116 | 105 | 2.2 | Mlig455_006245, Mlig455_006299, Mlig455_061192 | Neo: - Age: - |
ESRRB | 1.748 | - | 0.749 | 0.999 | - | - | - | Mlig455_006245 {REF} {Length: 450} {NoTransDecoderORF} Mlig455_006299 {REF} {Length: 2539} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=73.3]; Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=20.3]} {Human: ENSG00000119715, ESRRB, estrogen related receptor beta, [Score=94.4, Expect=2e-20]} {Mouse: ENSMUSG00000047638, Nr1h4, nuclear receptor subfamily 1, group H, member 4, [Score=88.2, Expect=1e-18]; ENSMUSG00000024955, Esrra, estrogen related receptor, alpha, [Score=86.7, Expect=3e-18]; ENSMUSG00000015846, Rxra, retinoid X receptor alpha, [Score=85.1, Expect=1e-17]; ENSMUSG00000023034, Nr4a1, nuclear receptor subfamily 4, group A, member 1, [Score=84.7, Expect=2e-17]} {Dmel: FBgn0035849, ERR, estrogen-related receptor, [Score=80.9, Expect=3e-16]} {Celegans: WBGene00003625, nhr-31, Nuclear hormone receptor family member nhr-31, [Score=84.3, Expect=2e-17]} {Smed: dd_Smed_v6_3012_0_1, dd_Smed_v6_3012_0_1, [Score=81.3, Expect=1e-16]} {RNA1310_86523} Mlig455_061192 {REF} {Length: 2120} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=73.2]; Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=19.6]} {Human: ENSG00000119715, ESRRB, estrogen related receptor beta, [Score=97.4, Expect=2e-21]} {Mouse: ENSMUSG00000047638, Nr1h4, nuclear receptor subfamily 1, group H, member 4, [Score=94.4, Expect=1e-20]} {Dmel: FBgn0035849, ERR, estrogen-related receptor, [Score=80.1, Expect=4e-16]} {Celegans: WBGene00003625, nhr-31, Nuclear hormone receptor family member nhr-31, [Score=84.3, Expect=2e-17]} {Smed: dd_Smed_v6_13691_0_1, dd_Smed_v6_13691_0_1, [Score=79.7, Expect=1e-16]} {RNA1310_86523} |
| 67. | MligTC455_47927 | 43 | 0.9 | Mlig455_029720 | Neo: - Age: - |
1.74 | - | 0.971 | 0.769 | - | - | - | Mlig455_029720 {REF} {Length: 2459} {RNA1509_35671} {RNA1310_75812} {RNA815_33002} | |
| 68. | MligTC455_29914 | 44 | 0.91 | Mlig455_027923 | Neo: - Age: Down-Up-Down Region-enriched R2: 8.096/0.00455 |
ANGPTL3 | 1.736 | 0.740 | - | 0.996 | - | - | - | Mlig455_027923 {REF} {Length: 1663} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=70.5]} {Human: ENSG00000132855, ANGPTL3, angiopoietin like 3, [Score=60.5, Expect=9e-10]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=59.3, Expect=2e-09]; ENSG00000120332, TNN, tenascin N, [Score=58.9, Expect=3e-09]} {Mouse: ENSMUSG00000015829, Tnr, tenascin R, [Score=62.4, Expect=2e-10]} {Dmel: FBgn0031804, CG9500, [Score=76.3, Expect=6e-16]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=51.2, Expect=3e-07]} {RNA1509_53291} {RNA1310_58974} {RNA815_43288.3} |
| 69. | MligTC455_29915 | 50 | 1.04 | Mlig455_027934 | Neo: - Age: Down-Up-Up Region-enriched R2: 6.881/0.04464 |
ANGPTL1 | 1.733 | 0.743 | - | 0.990 | - | - | - | Mlig455_027934 {REF} {Length: 2265} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=43.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=48.9, Expect=9e-06]} {Dmel: FBgn0031804, CG9500, [Score=53.1, Expect=9e-08]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=49.7, Expect=1e-06]} {RNA1509_53291} {RNA1310_38229.1} {RNA815_10579.1} |
| 70. | MligTC455_43557 | 362 | 7.55 | Mlig455_059172, Mlig455_065527 | Neo: - Age: Down-Down-Up Region-specific R2: 6.284 Region-enriched R2: 5.832/0.00001 |
ANKRD63 | 1.733 | - | - | 0.771 | 0.962 | - | - | Mlig455_059172 {REF} {Length: 1739} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=53.2]; Ankyrin repeats (many copies) [PF13637.8, score=42.6]; Ankyrin repeat [PF13606.8, score=27.6]; Ankyrin repeats (many copies) [PF13857.8, score=27.1]; Ankyrin repeat [PF00023.32, score=25.9]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [Score=68.2, Expect=7e-12]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [Score=67.4, Expect=7e-12]} {Dmel: FBgn0043884, mask, multiple ankyrin repeats single KH domain, [Score=49.3, Expect=7e-06]} {Celegans: WBGene00011240, R11A8.7, Ankyrin repeat and KH domain-containing protein R11A8.7, [Score=49.3, Expect=4e-06]} {Smed: dd_Smed_v6_10280_0_1, dd_Smed_v6_10280_0_1, [Score=81.3, Expect=1e-16]} {RNA1310_44826} {RNA815_62096} Mlig455_065527 {REF} {Length: 2998} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=52.3]; Ankyrin repeats (many copies) [PF13637.8, score=42.0]; Ankyrin repeats (many copies) [PF13857.8, score=26.7]; Ankyrin repeat [PF00023.32, score=26.0]; Ankyrin repeat [PF13606.8, score=22.6]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [Score=68.2, Expect=7e-12]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [Score=68.2, Expect=6e-12]} {Dmel: FBgn0043884, mask, multiple ankyrin repeats single KH domain, [Score=50.1, Expect=5e-06]} {Celegans: WBGene00011240, R11A8.7, Ankyrin repeat and KH domain-containing protein R11A8.7, [Score=50.4, Expect=2e-06]} {Smed: dd_Smed_v6_10280_0_1, dd_Smed_v6_10280_0_1, [Score=80.9, Expect=2e-16]} {RNA1509_30872} {RNA1310_44826} {RNA815_62096} |
| 71. | MligTC455_21583 | 64 | 1.33 | Mlig455_001407, Mlig455_064265 | Neo: - Age: - |
PDE8A | 1.732 | - | 0.781 | - | - | - | 0.951 | Mlig455_001407 {REF} {Length: 4083} {TRANSSPLICED} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=278.7]; PAS domain [PF13426.9, score=22.9]} {Human: ENSG00000073417, PDE8A, phosphodiesterase 8A, [Score=589, Expect=0.0]; ENSG00000113231, PDE8B, phosphodiesterase 8B, [Score=568, Expect=0.0]; ENSG00000284762, AC022414.1, phosphodiesterase 8B, [Score=565, Expect=0.0]} {Mouse: ENSMUSG00000025584, Pde8a, phosphodiesterase 8A, [Score=579, Expect=0.0]; ENSMUSG00000021684, Pde8b, phosphodiesterase 8B, [Score=569, Expect=0.0]} {Dmel: FBgn0266377, Pde8, Phosphodiesterase 8, [Score=357, Expect=4e-110]} {Celegans: WBGene00022389, pde-6, Probable 3',5'-cyclic phosphodiesterase pde-6, [RH, Score=312, Expect=6e-94]} {Smed: dd_Smed_v6_10593_0_1, dd_Smed_v6_10593_0_1, [Score=410, Expect=2e-130]} {RNA1509_38664} {RNA1310_9544} {RNA815_9009} Mlig455_064265 {REF} {Length: 3769} {TRANSSPLICED} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=279.8]} {Human: ENSG00000073417, PDE8A, phosphodiesterase 8A, [Score=519, Expect=2e-172]; ENSG00000113231, PDE8B, phosphodiesterase 8B, [Score=495, Expect=4e-162]} {Mouse: ENSMUSG00000025584, Pde8a, phosphodiesterase 8A, [Score=499, Expect=1e-164]; ENSMUSG00000021684, Pde8b, phosphodiesterase 8B, [Score=496, Expect=8e-164]} {Dmel: FBgn0266377, Pde8, Phosphodiesterase 8, [Score=361, Expect=5e-112]} {Celegans: WBGene00022389, pde-6, Probable 3',5'-cyclic phosphodiesterase pde-6, [RH, Score=313, Expect=2e-94]} {Smed: dd_Smed_v6_10593_0_2, dd_Smed_v6_10593_0_2, [Score=404, Expect=1e-128]} {RNA1509_38664} {RNA1310_9544} {RNA815_9009} |
| 72. | MligTC455_14713 | 17 | 0.36 | Mlig455_067463 | Neo: - Age: - Region-enriched R2: 8.201/0.03287 |
1.73 | 0.731 | - | 0.999 | - | - | - | Mlig455_067463 {REF} {Length: 1917} {RNA1310_74292} {RNA815_48878} | |
| 73. | MligTC455_09527 | 9 | 0.19 | Mlig455_003833 | Neo: - Age: - |
1.729 | - | - | 0.729 | 1.000 | - | - | Mlig455_003833 {REF} {Length: 456} {RNA1310_99936} {RNA815_40952} | |
| 74. | MligTC455_36800 | 19 | 0.41 | Mlig455_042163 | Neo: - Age: - |
1.729 | 0.738 | - | - | 0.991 | - | - | Mlig455_042163 {REF} {Length: 4866} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=139.5]} {Mouse: ENSMUSG00000000216, Scnn1g, sodium channel, nonvoltage-gated 1 gamma, [Score=57.4, Expect=3e-08]} {Celegans: WBGene00016064, acd-1, [Score=51.2, Expect=1e-06]} {Smed: dd_Smed_v6_13943_0_1, dd_Smed_v6_13943_0_1, [Score=81.3, Expect=4e-16]} {RNA1509_59040} {RNA1310_26501} {RNA815_11672.2} | |
| 75. | MligTC455_34525 | 52 | 1.08 | Mlig455_021566 | Neo: - Age: Down-Up-Down |
GNAI1 | 1.726 | 0.740 | - | 0.986 | - | - | - | Mlig455_021566 {REF} {Length: 3532} {Pfam: G-protein alpha subunit [PF00503.22, score=404.9]; ADP-ribosylation factor family [PF00025.23, score=56.0]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=20.1]; Gtr1/RagA G protein conserved region [PF04670.14, score=19.4]} {Human: ENSG00000127955, GNAI1, G protein subunit alpha i1, [Score=486, Expect=2e-171]; ENSG00000114353, GNAI2, G protein subunit alpha i2, [Score=481, Expect=3e-169]; ENSG00000065135, GNAI3, G protein subunit alpha i3, [Score=474, Expect=1e-166]} {Mouse: ENSMUSG00000057614, Gnai1, guanine nucleotide binding protein (G protein), alpha inhibiting 1, [Score=486, Expect=2e-171]; ENSMUSG00000032562, Gnai2, guanine nucleotide binding protein (G protein), alpha inhibiting 2, [Score=475, Expect=5e-167]; ENSMUSG00000000001, Gnai3, guanine nucleotide binding protein (G protein), alpha inhibiting 3, [Score=474, Expect=1e-166]} {Dmel: FBgn0001104, Galphai, G protein alpha i subunit, [Score=468, Expect=2e-164]} {Celegans: WBGene00001648, goa-1, Guanine nucleotide-binding protein G(o) subunit alpha, [Score=446, Expect=5e-156]} {Smed: dd_Smed_v6_12112_0_1, dd_Smed_v6_12112_0_1, [RH, Score=598, Expect=0.0]} {RNA1509_45426} {RNA1310_26920, RNA1509_45426} {RNA1509_45426, RNA815_11718} |
| 76. | MligTC455_53771 | 8 | 0.17 | Mlig455_049015 | Neo: - Age: - |
1.726 | - | - | 0.726 | 1.000 | - | - | Mlig455_049015 {REF} {Length: 1379} {Pfam: WSC domain [PF01822.21, score=49.2]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=46.6, Expect=1e-05]} | |
| 77. | MligTC455_13734 | 19 | 0.4 | Mlig455_066088 | Neo: - Age: Down-Up-Down |
1.724 | 0.724 | - | - | 1.000 | - | - | Mlig455_066088 {REF} {Length: 1207} {RNA1310_47485} {RNA815_44269} | |
| 78. | MligTC455_19679 | 66 | 1.38 | Mlig455_028164 | Neo: - Age: - Region-enriched R2: 5.194/0.00256 |
SLC7A11 | 1.723 | 0.756 | - | - | 0.967 | - | - | Mlig455_028164 {REF} {Length: 3562} {TRANSSPLICED} {Pfam: Amino acid permease [PF13520.8, score=187.6]; Amino acid permease [PF00324.23, score=95.8]} {Human: ENSG00000151012, SLC7A11, solute carrier family 7 member 11, [RH, Score=350, Expect=1e-115]} {Mouse: ENSMUSG00000027737, Slc7a11, solute carrier family 7 (cationic amino acid transporter, y+ system), member 11, [Score=370, Expect=2e-123]} {Dmel: FBgn0002778, mnd, minidiscs, [RH, Score=379, Expect=5e-127]} {Celegans: WBGene00000004, aat-3, Amino Acid Transporter, [Score=331, Expect=2e-108]} {Smed: dd_Smed_v6_4211_0_1, dd_Smed_v6_4211_0_1, [Score=465, Expect=3e-160]} {RNA1310_31710.1} {RNA815_14153} |
| 79. | MligTC455_53860 | 202 | 4.22 | Mlig455_053523, Mlig455_061000 | Neo: - Age: Up-Down-Down Region-enriched R2: 3.086/0.02665 |
RGS3 | 1.723 | - | 0.749 | 0.974 | - | - | - | Mlig455_053523 {REF} {Length: 2125} {Pfam: Regulator of G protein signaling domain [PF00615.21, score=117.0]} {Human: ENSG00000138835, RGS3, regulator of G protein signaling 3, [RH, Score=163, Expect=4e-45]} {Mouse: ENSMUSG00000059810, Rgs3, regulator of G-protein signaling 3, [RH, Score=165, Expect=2e-45]} {Dmel: FBgn0028743, Dhit, Double hit, [Score=109, Expect=2e-27]} {Celegans: WBGene00004350, rgs-7, Regulator of G-protein signaling rgs-7, [RH, Score=130, Expect=1e-34]} {Smed: dd_Smed_v6_8787_0_1, dd_Smed_v6_8787_0_1, [Score=173, Expect=9e-51]} {RNA1310_19330.1} {RNA815_18723} Mlig455_061000 {REF} {Length: 2721} {Pfam: Regulator of G protein signaling domain [PF00615.21, score=117.0]; Dehydrin [PF00257.21, score=20.5]} {Human: ENSG00000138835, RGS3, regulator of G protein signaling 3, [RH, Score=163, Expect=4e-45]} {Mouse: ENSMUSG00000059810, Rgs3, regulator of G-protein signaling 3, [RH, Score=165, Expect=2e-45]} {Dmel: FBgn0028743, Dhit, Double hit, [Score=109, Expect=2e-27]} {Celegans: WBGene00004350, rgs-7, Regulator of G-protein signaling rgs-7, [RH, Score=130, Expect=1e-34]} {Smed: dd_Smed_v6_8787_0_1, dd_Smed_v6_8787_0_1, [Score=173, Expect=8e-51]} {RNA1310_19330.1} {RNA815_18723} |
| 80. | MligTC455_09456 | 47 | 0.97 | Mlig455_029993 | Neo: - Age: - Region-enriched R2: 5.041/0.00960 |
1.721 | 0.755 | - | 0.966 | - | - | - | Mlig455_029993 {REF} {Length: 3167} {RNA1509_44134} {RNA1310_31411} {RNA815_45870} | |
| 81. | MligTC455_06448 | 13 | 0.26 | Mlig455_022314, Mlig455_069882 | Neo: - Age: - |
1.719 | - | 0.726 | 0.993 | - | - | - | Mlig455_022314 {REF} {Length: 354} {Pfam: Pancreatic hormone peptide [PF00159.20, score=26.8]} {RNA1310_54016} {RNA815_51613} Mlig455_069882 {REF} {Length: 365} {Pfam: Pancreatic hormone peptide [PF00159.20, score=29.8]} {RNA1310_54016} {RNA815_51613} |
|
| 82. | MligTC455_50029 | 35 | 0.74 | Mlig455_010619, Mlig455_010708 | Neo: - Age: - |
FOXA1 | 1.717 | - | - | 0.720 | 0.997 | - | - | Mlig455_010619 {REF} {Length: 1170} {Pfam: Forkhead domain [PF00250.20, score=110.8]} {Human: ENSG00000129514, FOXA1, forkhead box A1, [Score=168, Expect=3e-48]; ENSG00000170608, FOXA3, forkhead box A3, [Score=164, Expect=1e-47]; ENSG00000125798, FOXA2, forkhead box A2, [Score=163, Expect=2e-46]} {Mouse: ENSMUSG00000035451, Foxa1, forkhead box A1, [Score=167, Expect=3e-48]; ENSMUSG00000040891, Foxa3, forkhead box A3, [Score=164, Expect=7e-48]; ENSMUSG00000037025, Foxa2, forkhead box A2, [Score=164, Expect=7e-47]} {Dmel: FBgn0000659, fkh, fork head, [Score=169, Expect=2e-48]} {Celegans: WBGene00004013, pha-4, Defective pharyngeal development protein 4, [Score=150, Expect=3e-42]} {Smed: dd_Smed_v6_10718_0_4, dd_Smed_v6_10718_0_4, [Score=175, Expect=2e-51]} Mlig455_010708 {REF} {Length: 1194} {Pfam: Forkhead domain [PF00250.20, score=110.9]} {Human: ENSG00000129514, FOXA1, forkhead box A1, [Score=168, Expect=3e-48]; ENSG00000125798, FOXA2, forkhead box A2, [Score=163, Expect=2e-46]; ENSG00000170608, FOXA3, forkhead box A3, [Score=163, Expect=1e-47]} {Mouse: ENSMUSG00000035451, Foxa1, forkhead box A1, [Score=167, Expect=4e-48]; ENSMUSG00000040891, Foxa3, forkhead box A3, [Score=165, Expect=2e-48]; ENSMUSG00000037025, Foxa2, forkhead box A2, [Score=164, Expect=9e-47]} {Dmel: FBgn0000659, fkh, fork head, [Score=168, Expect=2e-48]} {Celegans: WBGene00004013, pha-4, Defective pharyngeal development protein 4, [Score=151, Expect=2e-42]} {Smed: dd_Smed_v6_10718_0_3, dd_Smed_v6_10718_0_3, [Score=175, Expect=2e-51]} |
| 83. | MligTC455_30634 | 114 | 2.38 | Mlig455_025888 | Neo: - Age: Up-Down-Up Region-enriched R2: 6.750/0.00140 |
1.716 | - | 0.951 | 0.765 | - | - | - | Mlig455_025888 {REF} {Length: 5266} {Pfam: Integrase core domain [PF00665.28, score=50.8]; DDE superfamily endonuclease [PF13358.8, score=22.0]} {Smed: dd_Smed_v6_1574_6_72, dd_Smed_v6_1574_6_72, [Score=149, Expect=3e-41]} {RNA1509_47056} {RNA1310_5710.1} {RNA815_6291.1} | |
| 84. | MligTC455_53720 | 144 | 2.99 | Mlig455_028516 | Neo: - Age: - Region-enriched R2: 4.205/0.01762 |
CTBP2 | 1.715 | - | 0.757 | 0.958 | - | - | - | Mlig455_028516 {REF} {Length: 3357} {TRANSSPLICED} {Pfam: D-isomer specific 2-hydroxyacid dehydrogenase, NAD binding domain [PF02826.21, score=112.7]; D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain [PF00389.32, score=67.2]; THAP domain [PF05485.14, score=38.8]; NAD binding domain of 6-phosphogluconate dehydrogenase [PF03446.17, score=22.2]} {Human: ENSG00000175029, CTBP2, C-terminal binding protein 2, [Score=370, Expect=3e-115]; ENSG00000159692, CTBP1, C-terminal binding protein 1, [Score=360, Expect=1e-117]} {Mouse: ENSMUSG00000030970, Ctbp2, C-terminal binding protein 2, [Score=372, Expect=5e-116]; ENSMUSG00000037373, Ctbp1, C-terminal binding protein 1, [Score=362, Expect=8e-119]} {Dmel: FBgn0020496, CtBP, C-terminal Binding Protein, [Score=354, Expect=1e-116]} {Celegans: WBGene00006424, ctbp-1, C-terminal-binding protein 1, [Score=475, Expect=8e-159]} {Smed: dd_Smed_v6_1063_0_1, dd_Smed_v6_1063_0_1, [Score=354, Expect=3e-115]} {RNA1310_37204} {RNA815_48484} |
| 85. | MligTC455_16437 | 38 | 0.79 | Mlig455_025875 | Neo: - Age: - |
1.712 | 0.739 | - | 0.973 | - | - | - | Mlig455_025875 {REF} {Length: 1498} {RNA1310_46570} {RNA815_39675} | |
| 86. | MligTC455_20225 | 18 | 0.38 | Mlig455_042403 | Neo: - Age: - |
1.711 | - | - | 0.720 | 0.991 | - | - | Mlig455_042403 {REF} {Length: 1402} {Pfam: WSC domain [PF01822.21, score=50.0]; PAN domain [PF00024.28, score=21.0]} {RNA1310_77268} {RNA815_27180} | |
| 87. | MligTC455_22501 | 73 | 1.51 | Mlig455_036417 | Neo: - |
SLC6A4 | 1.708 | - | - | 0.708 | 1.000 | - | - | Mlig455_036417 {REF} {Length: 3681} {Pfam: Sodium:neurotransmitter symporter family [PF00209.20, score=681.8]} {Human: ENSG00000108576, SLC6A4, solute carrier family 6 member 4, [RH, Score=610, Expect=0.0]} {Mouse: ENSMUSG00000020838, Slc6a4, solute carrier family 6 (neurotransmitter transporter, serotonin), member 4, [RH, Score=599, Expect=0.0]} {Dmel: FBgn0010414, SerT, Serotonin transporter, [RH, Score=631, Expect=0.0]} {Celegans: WBGene00003387, mod-5, Transporter, [RH, Score=559, Expect=0.0]} {Smed: dd_Smed_v6_12700_0_1, dd_Smed_v6_12700_0_1, [RH, Score=691, Expect=0.0]} {RNA1509_33614} {RNA1310_10815, RNA1509_33614} {RNA1509_33614, RNA815_8003} |
| 88. | MligTC455_34524 | 155 | 3.22 | Mlig455_021291 | Neo: - Age: Down-Up-Down Region-specific R2: 4.905 Region-enriched R2: 4.200/0.01842 |
1.708 | 0.721 | - | 0.987 | - | - | - | Mlig455_021291 {REF} {Length: 1478} {NoTransDecoderORF} {RNA1509_56543} {RNA1310_26920, RNA1509_56543} {RNA1509_56543, RNA815_11718} | |
| 89. | MligTC455_39988 | 83 | 1.73 | Mlig455_062081 | Neo: - Age: - |
1.707 | 0.739 | - | 0.968 | - | - | - | Mlig455_062081 {REF} {Length: 447} {NoTransDecoderORF} {RNA1509_50426} {RNA1310_88257} {RNA815_17173.4} | |
| 90. | MligTC455_14856 | 14 | 0.29 | Mlig455_023184 | Neo: - Age: - |
ANGPTL7 | 1.706 | - | - | 0.983 | 0.723 | - | - | Mlig455_023184 {REF} {Length: 1290} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=129.4]; PAN domain [PF00024.28, score=23.8]} {Human: ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=105, Expect=1e-25]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=103, Expect=3e-24]} {Mouse: ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=104, Expect=1e-25]; ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=102, Expect=4e-24]} {Dmel: FBgn0033312, CG8642, [Score=96.7, Expect=2e-22]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=98.6, Expect=5e-23]} {RNA1509_58115} {RNA1310_36699.1} {RNA815_17918.1} |
| 91. | MligTC455_43137 | 118 | 2.46 | Mlig455_043159 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.878 Region-enriched R2: 5.988/0.00166 |
1.705 | 0.744 | 0.961 | - | - | - | - | Mlig455_043159 {REF} {Length: 1651} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=25.7]} {RNA1509_48871} {RNA1310_23692, RNA1509_48871} {RNA1509_48871, RNA815_11317} | |
| 92. | MligTC455_44025 | 591 | 12.31 | Mlig455_050980 | Neo: - Age: - Region-specific R2: 5.366 Region-enriched R2: 5.986/0.00000 |
1.705 | 0.724 | - | 0.981 | - | - | - | Mlig455_050980 {REF} {Length: 587} {Smed: dd_Smed_v6_2575_0_1, dd_Smed_v6_2575_0_1, [Score=49.7, Expect=7e-09]} {RNA1509_52032} {RNA1310_52449.2} {RNA815_56904} | |
| 93. | MligTC455_23239 | 32 | 0.67 | Mlig455_030867 | Neo: - Age: - |
PRKCB | 1.703 | 0.715 | 0.988 | - | - | - | - | Mlig455_030867 {REF} {Length: 3999} {Pfam: Protein kinase domain [PF00069.27, score=228.1]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=131.0]; Phorbol esters/diacylglycerol binding domain (C1 domain) [PF00130.24, score=118.5]; C2 domain [PF00168.32, score=93.9]; Protein kinase C terminal domain [PF00433.26, score=35.3]; C1 domain [PF03107.18, score=22.2]; Kinase-like [PF14531.8, score=19.0]} {Human: ENSG00000166501, PRKCB, protein kinase C beta, [RH, Score=962, Expect=0.0]; ENSG00000154229, PRKCA, protein kinase C alpha, [RH, Score=952, Expect=0.0]} {Mouse: ENSMUSG00000052889, Prkcb, protein kinase C, beta, [RH, Score=963, Expect=0.0]; ENSMUSG00000050965, Prkca, protein kinase C, alpha, [RH, Score=952, Expect=0.0]} {Dmel: FBgn0003091, Pkc53E, Protein C kinase 53E, [RH, Score=941, Expect=0.0]} {Celegans: WBGene00004033, pkc-2, Protein kinase C-like 2, [RH, Score=940, Expect=0.0]} {Smed: dd_Smed_v6_4244_0_2, dd_Smed_v6_4244_0_2, [RH, Score=1049, Expect=0.0]} {RNA1509_51260} {RNA1310_9698, RNA1509_51260} {RNA1509_51260, RNA815_24870} |
| 94. | MligTC455_19304 | 36 | 0.76 | Mlig455_036451 | Neo: - Age: - |
1.7 | - | - | 0.995 | 0.705 | - | - | Mlig455_036451 {REF} {Length: 1603} {Smed: dd_Smed_v6_16261_0_1, dd_Smed_v6_16261_0_1, [RH, Score=266, Expect=8e-87]} {RNA1310_117429} | |
| 95. | MligTC455_32025 | 18 | 0.36 | Mlig455_028181, Mlig455_028252 | Neo: - |
1.698 | 0.725 | - | 0.973 | - | - | - | Mlig455_028181 {REF} {Length: 4403} {Pfam: PH domain [PF00169.31, score=19.7]} {RNA1310_106355} Mlig455_028252 {REF} {Length: 3659} {Pfam: PH domain [PF00169.31, score=20.0]} {RNA1310_106355} |
|
| 96. | MligTC455_30463 | 95 | 1.98 | Mlig455_000250, Mlig455_058521, Mlig455_058532 | Neo: - Age: - |
1.696 | 0.703 | - | 0.993 | - | - | - | Mlig455_000250 {REF} {Length: 1994} {Pfam: Transcription factor IIA, alpha/beta subunit [PF03153.15, score=19.7]} {RNA1310_59451} {RNA815_40085} Mlig455_058521 {REF} {Length: 1237} {RNA1310_56656} {RNA815_40085} Mlig455_058532 {REF} {Length: 1973} {Pfam: Transcription factor IIA, alpha/beta subunit [PF03153.15, score=19.5]} {RNA1310_59451} {RNA815_40085} |
|
| 97. | MligTC455_31685 | 83 | 1.73 | Mlig455_036333, Mlig455_036334, Mlig455_036356, Mlig455_054550 | Neo: - Age: - |
SLC5A7 | 1.696 | - | 0.720 | 0.976 | - | - | - | Mlig455_036333 {REF} {Length: 491} {tRNA: Ala(CGC),pseudo, score=26.8} {RNA1509_45595} {RNA1310_13430.1} {RNA815_31014} Mlig455_036334 {REF} {Length: 599} {NoTransDecoderORF} {RNA1310_51434} {RNA815_35996} Mlig455_036356 {REF} {Length: 4094} {tRNA: Ala(CGC),pseudo, score=26.8} {Pfam: Sodium:solute symporter family [PF00474.19, score=114.3]} {Human: ENSG00000115665, SLC5A7, solute carrier family 5 member 7, [RH, Score=591, Expect=0.0]} {Mouse: ENSMUSG00000023945, Slc5a7, solute carrier family 5 (choline transporter), member 7, [RH, Score=595, Expect=0.0]} {Dmel: FBgn0038641, CG7708, [RH, Score=602, Expect=0.0]} {Celegans: WBGene00000501, cho-1, High-affinity choline transporter 1, [RH, Score=553, Expect=0.0]} {Smed: dd_Smed_v6_12883_0_1, dd_Smed_v6_12883_0_1, [RH, Score=649, Expect=0.0]} {RNA1509_56795} {RNA1310_15022.1} {RNA815_33275} Mlig455_054550 {REF} {Length: 303} {NoTransDecoderORF} {RNA1509_46688} {RNA1310_146263} {RNA815_62938} |
| 98. | MligTC455_26690 | 58 | 1.2 | Mlig455_044790 | Neo: - Age: - |
PDE9A | 1.695 | 0.739 | - | 0.956 | - | - | - | Mlig455_044790 {REF} {Length: 2883} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=286.3]} {Human: ENSG00000160191, PDE9A, phosphodiesterase 9A, [RH, Score=604, Expect=0.0]} {Mouse: ENSMUSG00000041119, Pde9a, phosphodiesterase 9A, [RH, Score=605, Expect=0.0]} {Dmel: FBgn0259171, Pde9, Phosphodiesterase 9, [RH, Score=353, Expect=3e-108]} {Celegans: WBGene00020114, pde-4, Probable 3',5'-cyclic phosphodiesterase pde-4, [Score=186, Expect=5e-52]} {Smed: dd_Smed_v6_13304_0_1, dd_Smed_v6_13304_0_1, [RH, Score=328, Expect=6e-106]} {RNA1310_14017} {RNA815_23817} |
| 99. | MligTC455_31163 | 72 | 1.51 | Mlig455_045625 | Neo: - Age: Up-Down-Down |
1.694 | 0.731 | - | 0.963 | - | - | - | Mlig455_045625 {REF} {Length: 1957} {RNA1509_21720} {RNA1310_14760, RNA1509_21720} {RNA1509_21720, RNA815_24583} | |
| 100. | MligTC455_35773 | 89 | 1.86 | Mlig455_064449, Mlig455_064456 | Neo: - Age: - Region-enriched R2: 5.198/0.00725 |
NANP | 1.693 | 0.738 | - | 0.955 | - | - | - | Mlig455_064449 {REF} {Length: 503} {NoTransDecoderORF} {RNA1310_53432.2} Mlig455_064456 {REF} {Length: 3122} {Pfam: Haloacid dehalogenase-like hydrolase [PF13419.8, score=56.3]; haloacid dehalogenase-like hydrolase [PF00702.28, score=55.3]; HAD-hyrolase-like [PF13242.8, score=44.6]} {Human: ENSG00000170191, NANP, N-acetylneuraminic acid phosphatase, [RH, Score=47.4, Expect=8e-06]} {Mouse: ENSMUSG00000053916, Nanp, N-acetylneuraminic acid phosphatase, [RH, Score=48.5, Expect=2e-06]} {Celegans: WBGene00018465, F45E1.4, [RH, Score=147, Expect=4e-43]} {Smed: dd_Smed_v6_2813_0_3, dd_Smed_v6_2813_0_3, [Score=174, Expect=2e-50]} {RNA1310_59243} {RNA815_62364} |
There are 481 more genes with r >= 0.95